tak 779 has been researched along with uc-781 in 1 studies
Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (uc-781) | Trials (uc-781) | Recent Studies (post-2010) (uc-781) |
---|---|---|---|---|---|
118 | 1 | 35 | 70 | 6 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckheit, RW; Cummins, JE; Lackman-Smith, C; Lewis, G; Luckenbaugh, K; Mankowski, M; Osterling, C; Paull, J; Profy, A; Ptak, RG; Sanders-Beer, BE; Snyder, B; Watson, KM | 1 |
1 other study(ies) available for tak 779 and uc-781
Article | Year |
---|---|
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.
Topics: Algorithms; Amides; Anilides; Anti-HIV Agents; Anti-Infective Agents, Local; CCR5 Receptor Antagonists; CD4 Antigens; Cell Line; Drug Evaluation, Preclinical; Furans; HeLa Cells; HIV-1; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Naphthalenesulfonates; Polymers; Quaternary Ammonium Compounds; Receptors, CXCR4; Thioamides | 2008 |